The prominent KMT2A rearrangement partner, MLLT3, is the most common of all KMT2A rearrangements in infant AML and is associated with both myelomonocytic leukemia (AMML) and AMKL [87,94]. This evidence concerns the gene MLLT3 and acute myeloid leukemia.